CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of 469.60 million. The enterprise value is 452.80 million.

Market Cap	469.60M
Enterprise Value	452.80M

Important Dates

The next estimated earnings date is Friday, July 18, 2025.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	23.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	19.82M

Valuation Ratios

The trailing PE ratio is 30.99 and the forward PE ratio is 24.85.

PE Ratio	30.99
Forward PE	24.85
PS Ratio	6.30
PB Ratio	5.62
P/TBV Ratio	7.47
P/FCF Ratio	26.93
P/OCF Ratio	25.01
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.80, with an EV/FCF ratio of 25.97.

EV / Earnings	29.88
EV / Sales	5.74
EV / EBITDA	18.80
EV / EBIT	21.92
EV / FCF	25.97

Financial Position

The company has a current ratio of 3.69, with a Debt / Equity ratio of 0.03.

Current Ratio	3.69
Quick Ratio	2.68
Debt / Equity	0.03
Debt / EBITDA	0.10
Debt / FCF	0.13
Interest Coverage	40.27

Financial Efficiency

Return on equity (ROE) is 19.05% and return on invested capital (ROIC) is 14.61%.

Return on Equity (ROE)	19.05%
Return on Assets (ROA)	12.14%
Return on Invested Capital (ROIC)	14.61%
Return on Capital Employed (ROCE)	21.19%
Revenue Per Employee	326,808
Profits Per Employee	66,468
Employee Count	219
Asset Turnover	0.74
Inventory Turnover	1.95

Taxes

In the past 12 months, CellaVision AB has paid 3.89 million in taxes.

Income Tax	3.89M
Effective Tax Rate	20.41%

Stock Price Statistics

The stock price has increased by +15.31% in the last 52 weeks. The beta is 1.23, so CellaVision AB's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	+15.31%
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	45.66
Average Volume (20 Days)	535

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of 74.51 million and earned 15.15 million in profits. Earnings per share was 0.64.

Revenue	74.51M
Gross Profit	51.03M
Operating Income	19.52M
Pretax Income	19.04M
Net Income	15.15M
EBITDA	21.57M
EBIT	19.52M
Earnings Per Share (EPS)	0.64

Full Income Statement

Balance Sheet

The company has 18.16 million in cash and 2.29 million in debt, giving a net cash position of 15.88 million.

Cash & Cash Equivalents	18.16M
Total Debt	2.29M
Net Cash	15.88M
Net Cash Per Share	n/a
Equity (Book Value)	83.54M
Book Value Per Share	3.50
Working Capital	31.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.78 million and capital expenditures -1.34 million, giving a free cash flow of 17.44 million.

Operating Cash Flow	18.78M
Capital Expenditures	-1.34M
Free Cash Flow	17.44M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.48%, with operating and profit margins of 26.20% and 20.34%.

Gross Margin	68.48%
Operating Margin	26.20%
Pretax Margin	25.55%
Profit Margin	20.34%
EBITDA Margin	28.94%
EBIT Margin	26.20%
FCF Margin	23.40%

Dividends & Yields

CellaVision AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	35.28%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	3.23%
FCF Yield	3.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7